Literature DB >> 27872390

Classifying diabetes-burden: A factor analysis of the Problem Areas in Diabetes Scale.

Colleen E Martin1, Brenna N Renn1,2,3, Kate E Winderman1, Natalie Hundt1,2,3,4, Nancy J Petersen1,3, Aanand D Naik1,2,3, Jeffrey A Cully1,2,3,4.   

Abstract

This study sought to identify salient factors associated with the Problem Areas in Diabetes Scale to facilitate improved assessment and treatment of diabetes-related burden. Exploratory factor analysis assessed the factor structure of the Problem Areas in Diabetes Scale among 224 Veterans with uncontrolled type 2 diabetes and depressive symptoms. A four-factor solution of emotional, diabetes management, treatment, and social support burden subscales was extracted. These factors represent clinically relevant components of diabetes burden that include but go beyond symptoms of depression. The Problem Areas in Diabetes subscales may expand assessments for depression and improve medical and behavioral health interventions for patients with diabetes.

Entities:  

Keywords:  Veteran; depression; diabetes; diabetes-related distress; illness burden

Mesh:

Year:  2016        PMID: 27872390     DOI: 10.1177/1359105316678667

Source DB:  PubMed          Journal:  J Health Psychol        ISSN: 1359-1053


  2 in total

1.  Test-retest reliability and measurement error of the WHO-5 Well-being Index and the Problem Areas in Diabetes questionnaire (PAID) used in telehealth among patients with type 1 diabetes.

Authors:  Liv Marit Valen Schougaard; Tinne Laurberg; Kirsten Lomborg; Troels Krarup Hansen; Niels Henrik Hjollund; Annesofie Lunde Jensen
Journal:  J Patient Rep Outcomes       Date:  2022-09-23

2.  Testing the Impact of a Collaborative, Goal-Setting, and Behavioral Telehealth Intervention on Diabetes Distress: A Randomized Clinical Trial.

Authors:  Elizabeth M Vaughan; Jeffrey A Cully; Nancy J Petersen; Natalie E Hundt; Mark E Kunik; Darrell D Zeno; Aanand D Naik
Journal:  Telemed J E Health       Date:  2021-03-15       Impact factor: 3.536

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.